Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, Thailand.
Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, Thailand; Office of Academic Management, Faculty of Allied Health Sciences, Burapha University, Chonburi, Thailand.
Arch Biochem Biophys. 2018 Feb 15;640:10-16. doi: 10.1016/j.abb.2017.12.022. Epub 2018 Jan 6.
Overdose of oral calcium supplement and excessive intestinal calcium absorption can contribute pathophysiological conditions, e.g., nephrolithiasis, vascular calcification, dementia, and cardiovascular accident. Since our previous investigation has indicated that fibroblast growth factor (FGF)-23 could abolish the 1,25-dihydroxyvitamin D [1,25(OH)D]-enhanced calcium absorption, we further hypothesized that FGF-23 produced locally in the enterocytes might be part of a local negative feedback loop to regulate calcium absorption. Herein, 1,25(OH)D was found to enhance the transcellular calcium transport across the epithelium-like Caco-2 monolayer, and this stimulatory effect was diminished by preceding prolonged exposure to high-dose 1,25(OH)D or high concentration of apical ionized calcium. Pretreatment with a neutralizing antibody for FGF-23 prevented this negative feedback regulation of calcium hyperabsorption induced by 1,25(OH)D. FGF-23 exposure completely abolished the 1,25(OH)D-enhanced calcium transport. Western blot analysis revealed that FGF-23 expression was upregulated in a dose-dependent manner by 1,25(OH)D or apical calcium exposure. Finally, calcium-sensing receptor (CaSR) inhibitors were found to prevent the apical calcium-induced suppression of calcium transport. In conclusion, prolonged exposure to high apical calcium and calcium hyperabsorption were sensed by CaSR, which, in turn, increased FGF-23 expression to suppress calcium transport. This local negative feedback loop can help prevent unnecessary calcium uptake and its detrimental consequences.
口服钙补充剂过量和肠道过度钙吸收可导致肾结石、血管钙化、痴呆和心血管意外等病理生理状况。由于我们之前的研究表明成纤维细胞生长因子 23(FGF-23)可以消除 1,25-二羟维生素 D [1,25(OH)2D]增强的钙吸收,我们进一步假设在肠细胞中局部产生的 FGF-23 可能是调节钙吸收的局部负反馈回路的一部分。在此,我们发现 1,25(OH)2D 增强了上皮样 Caco-2 单层细胞的跨细胞钙转运,而这种刺激作用在前瞻性长时间暴露于高剂量 1,25(OH)2D 或高浓度的顶端离子钙后减弱。用中和 FGF-23 的抗体预处理可防止 1,25(OH)2D 诱导的钙过度吸收的这种负反馈调节。FGF-23 暴露完全消除了 1,25(OH)2D 增强的钙转运。Western blot 分析显示,1,25(OH)2D 或顶端钙暴露以剂量依赖性方式上调 FGF-23 的表达。最后,发现钙敏感受体(CaSR)抑制剂可预防顶端钙诱导的钙转运抑制。总之,长时间暴露于高顶端钙和钙过度吸收会被 CaSR 感知,CaSR 反过来会增加 FGF-23 的表达以抑制钙转运。这种局部负反馈回路有助于防止不必要的钙摄取及其有害后果。